Céline Bourigault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Céline Bourigault has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
D. Lepelletier
Bacteriology and Hygiene Department, Nantes University Hospital, Nantes, France; Endoscope Reprocessing Unit (CeTrES), Nantes University Hospital, Nantes, France
2 shared publications- Didier Lepelletier
Nantes University Hospital
2 shared publications G. Birgand
Regional Center for Infection Prevention and Control, Nantes, France
2 shared publicationsM.-E. Juvin
Bacteriology and Hygiene Department, Nantes University Hospital, Nantes, France
2 shared publicationsA. Guillouzouic
1 shared publicationA. Reynaud
1 shared publication
Latest Publications
- Open Access
- 11 August 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (16) , 3521
Risk Factors Associated with 30-Day Mortality in Older Patients with Influenza
Background: Influenza is a common viral condition, but factors related to short-term mortality have not been fully studied in older adults. Our objective was to determine whether there is an association between geriatric factors and 30-day mortality. Methods: This was a retrospective cohort design. All patients aged 75 years and over, with a diagnosis of influenza confirmed by a positive RT-PCR, were included. The primary endpoint was death within the 30 days after diagnosis. Results: 114 patients were included; 14 (12.3%) patients died within 30 days. In multivariate analysis these patients were older (OR: 1.37 95% CI (1.05, 1.79), p = 0.021), and had a lower ADL score (OR: 0.36 95% CI (0, 17; 0.75), p = 0.006), and a higher SOFA score (OR: 2.30 95% CI (1.07, 4.94), p = 0.03). Oseltamivir treatment, initiated within the first 48 h, was independently associated with survival (OR: 0.04 95% CI (0.002, 0.78), p = 0.034). Conclusions: Identification of mortality risk factors makes it possible to consider specific secondary prevention measures such as the rapid introduction of antiviral treatment. Combined with primary prevention, these measures could help to limit the mortality associated with influenza in older patients.
- 11 August 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (16) , 3521
Open AccessRisk Factors Associated with 30-Day Mortality in Older Patients with Influenza
Background: Influenza is a common viral condition, but factors related to short-term mortality have not been fully studied in older adults. Our objective was to determine whether there is an association between geriatric factors and 30-day mortality. Methods: This was a retrospective cohort design. All patients aged 75 years and over, with a diagnosis of influenza confirmed by a positive RT-PCR, were included. The primary endpoint was death within the 30 days after diagnosis. Results: 114 patients were included; 14 (12.3%) patients died within 30 days. In multivariate analysis these patients were older (OR: 1.37 95% CI (1.05, 1.79), p = 0.021), and had a lower ADL score (OR: 0.36 95% CI (0, 17; 0.75), p = 0.006), and a higher SOFA score (OR: 2.30 95% CI (1.07, 4.94), p = 0.03). Oseltamivir treatment, initiated within the first 48 h, was independently associated with survival (OR: 0.04 95% CI (0.002, 0.78), p = 0.034). Conclusions: Identification of mortality risk factors makes it possible to consider specific secondary prevention measures such as the rapid introduction of antiviral treatment. Combined with primary prevention, these measures could help to limit the mortality associated with influenza in older patients.
- 1 August 2018
- Published by Elsevier in Journal of Hospital Infection
- Vol. 99 (4) , 422-426
Duodenoscopy: an amplifier of cross-transmission during a carbapenemase-producing Enterobacteriaceae outbreak in a gastroenterology pathway
- 1 August 2018
- Published by Elsevier in Journal of Hospital Infection
- Vol. 99 (4) , 422-426
Duodenoscopy: an amplifier of cross-transmission during a carbapenemase-producing Enterobacteriaceae outbreak in a gastroenterology pathway
- 1 May 2018
- Published by Societe de Reanimation de Langue Francaise in Médecine Intensive Réanimation
- Vol. 27 (3) , 204-210
Quelle surveillance des infections associées aux soins en réanimation en 2018 ?
La surveillance des infections associées aux soins (IAS) est prioritaire en réanimation, secteur à haut risque du fait de l’état critique des patients et de leur exposition aux dispositifs invasifs. Elle présente un triple objectif : décrire l’épidémiologie et l’incidence des IAS ; évaluer l’impact des actions de prévention ou de contrôle et alerter face à une épidémie ou des phénomènes émergents. Cette surveillance des IAS peut être réalisée selon une méthodologie interne, définie par l’établissement, ou intégrée à un réseau de surveillance. L’intérêt de la surveillance pour la prévention des IAS en réanimation n’est plus à démontrer, mais la surveillance manuelle reste chronophage pour les cliniciens et les équipes d’hygiène, limitant ainsi le temps dédié à la prévention de ces infections. La surveillance automatisée apparaît aujourd’hui comme un outil intéressant, tant par ses performances que par le gain de temps qu’elle représente pour les équipes. Plusieurs éléments sont primordiaux pour obtenir des résultats fiables : la nécessité d’une harmonisation des définitions et des méthodes de surveillance ; la mise à disposition d’outils informatiques performants pour faciliter le suivi des patients ; le leadership des réanimateurs dans la surveillance. Cet article fait le point sur les méthodes de surveillance des IAS utilisées aujourd’hui en réanimation, l’intérêt de la mise en place de cette surveillance épidémiologique ainsi que la fiabilité des données recueillies et, enfin, les avantages du développement d’une surveillance semiautomatisée ou automatisée des IAS dans ce secteur. Surveillance of healthcare-associated infections (HAI) is a priority in intensive care units (ICU), a specialty with the highest prevalence of HAI because of critical patients and their exposure to invasive devices. Surveillance of HAI has three objectives: describe the epidemiology and incidence of HAIs; assess the impact of prevention measures; and detect outbreaks or emerging infectious diseases. Specific or standardized methods can be used for HAIs monitoring. Although surveillance is an essential part of an effective infection prevention and control program, manual surveillance consumes too much time for clinicians and infection control teams, limiting the time available for education and HAIs prevention. Automated surveillance is presented as a method with good performances and time effectiveness. Several components are necessary to produce reliable results: use of standardized definitions and methodology, investment in electronic infrastructure to make patient follow-up easier; and leadership of clinicians in surveillance. This article reviews the methodology of HAIs standardized surveillance used in ICU, the objectives of epidemiological surveillance as well as the reliability of the collected data, and finally, the advantages of developing automated surveillance of HAIs in ICU.
- 1 May 2018
- Published by Societe de Reanimation de Langue Francaise in Médecine Intensive Réanimation
- Vol. 27 (3) , 204-210
Quelle surveillance des infections associées aux soins en réanimation en 2018 ?
La surveillance des infections associées aux soins (IAS) est prioritaire en réanimation, secteur à haut risque du fait de l’état critique des patients et de leur exposition aux dispositifs invasifs. Elle présente un triple objectif : décrire l’épidémiologie et l’incidence des IAS ; évaluer l’impact des actions de prévention ou de contrôle et alerter face à une épidémie ou des phénomènes émergents. Cette surveillance des IAS peut être réalisée selon une méthodologie interne, définie par l’établissement, ou intégrée à un réseau de surveillance. L’intérêt de la surveillance pour la prévention des IAS en réanimation n’est plus à démontrer, mais la surveillance manuelle reste chronophage pour les cliniciens et les équipes d’hygiène, limitant ainsi le temps dédié à la prévention de ces infections. La surveillance automatisée apparaît aujourd’hui comme un outil intéressant, tant par ses performances que par le gain de temps qu’elle représente pour les équipes. Plusieurs éléments sont primordiaux pour obtenir des résultats fiables : la nécessité d’une harmonisation des définitions et des méthodes de surveillance ; la mise à disposition d’outils informatiques performants pour faciliter le suivi des patients ; le leadership des réanimateurs dans la surveillance. Cet article fait le point sur les méthodes de surveillance des IAS utilisées aujourd’hui en réanimation, l’intérêt de la mise en place de cette surveillance épidémiologique ainsi que la fiabilité des données recueillies et, enfin, les avantages du développement d’une surveillance semiautomatisée ou automatisée des IAS dans ce secteur. Surveillance of healthcare-associated infections (HAI) is a priority in intensive care units (ICU), a specialty with the highest prevalence of HAI because of critical patients and their exposure to invasive devices. Surveillance of HAI has three objectives: describe the epidemiology and incidence of HAIs; assess the impact of prevention measures; and detect outbreaks or emerging infectious diseases. Specific or standardized methods can be used for HAIs monitoring. Although surveillance is an essential part of an effective infection prevention and control program, manual surveillance consumes too much time for clinicians and infection control teams, limiting the time available for education and HAIs prevention. Automated surveillance is presented as a method with good performances and time effectiveness. Several components are necessary to produce reliable results: use of standardized definitions and methodology, investment in electronic infrastructure to make patient follow-up easier; and leadership of clinicians in surveillance. This article reviews the methodology of HAIs standardized surveillance used in ICU, the objectives of epidemiological surveillance as well as the reliability of the collected data, and finally, the advantages of developing automated surveillance of HAIs in ICU.
- 7 September 2016
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 36 (1) , 57-63
Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case–control study
The aim of this study was to evaluate whether recent systemic anti-inflammatory agents (AIAs) exposure in patients with sore throat managed with or without antibiotic therapy influenced the risk of peritonsillar abscess (PTA). We conducted a multicenter case–control study in 13 French university hospitals in 2009–2012 comparing patients admitted with PTA to matched controls: patients with sore throat but without PTA who were followed up for 10 days after visiting their primary-care physician. In the multivariate stepwise logistic regression model comparing 120 cases with PTA to 143 controls, factors significantly associated with PTA were male gender (odds ratio [OR], 2.0; p = 0.03), smoking (OR, 2.0; p = 0.03), and prior self-medication with systemic AIAs (OR, 3.5; p = 0.01). Topical treatment was associated with significant protection against PTA (OR, 0.3; p < 0.001). In conclusion, self-medication with systemic AIAs appears to be an independent factor associated with the occurrence of PTA. This is an important message as non-steroidal AIAs access is favored by their over-counter availability in pharmacies. This finding must be interpreted with caution due to the study design and a prospective, randomized study is needed to substantiate these possible causal risk factors.
- 7 September 2016
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 36 (1) , 57-63
Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case–control study
The aim of this study was to evaluate whether recent systemic anti-inflammatory agents (AIAs) exposure in patients with sore throat managed with or without antibiotic therapy influenced the risk of peritonsillar abscess (PTA). We conducted a multicenter case–control study in 13 French university hospitals in 2009–2012 comparing patients admitted with PTA to matched controls: patients with sore throat but without PTA who were followed up for 10 days after visiting their primary-care physician. In the multivariate stepwise logistic regression model comparing 120 cases with PTA to 143 controls, factors significantly associated with PTA were male gender (odds ratio [OR], 2.0; p = 0.03), smoking (OR, 2.0; p = 0.03), and prior self-medication with systemic AIAs (OR, 3.5; p = 0.01). Topical treatment was associated with significant protection against PTA (OR, 0.3; p < 0.001). In conclusion, self-medication with systemic AIAs appears to be an independent factor associated with the occurrence of PTA. This is an important message as non-steroidal AIAs access is favored by their over-counter availability in pharmacies. This finding must be interpreted with caution due to the study design and a prospective, randomized study is needed to substantiate these possible causal risk factors.
- 1 November 2013
- Published by Elsevier in European Geriatric Medicine
- Vol. 4 (5) , 319-323
Assessment of a new oral health index in the elderly. A new oral health index
- 1 November 2013
- Published by Elsevier in European Geriatric Medicine
- Vol. 4 (5) , 319-323
Assessment of a new oral health index in the elderly. A new oral health index
- 1 July 2013
- Published by Elsevier in American Journal of Infection Control
- Vol. 41 (7) , 652-653
Investigation and management of multidrug-resistant Acinetobacter baumannii spread in a French medical intensive care unit: One outbreak may hide another
- 1 July 2013
- Published by Elsevier in American Journal of Infection Control
- Vol. 41 (7) , 652-653
Investigation and management of multidrug-resistant Acinetobacter baumannii spread in a French medical intensive care unit: One outbreak may hide another